Publications

Here is a selection of some of Ray’s recent journalism, his media publications and academic articles. Apologies if some of the links no longer work. For a full list of Ray’s academic publications, please visit pubmed.

  • Albarqouni L, Moynihan R, Clark J et al. Head of bed elevation to relieve gastroesophageal reflux symptoms: A systematic review. BMC Family Practice (2021) 22:24 https://doi.org/10.1186/s12875-021-01369-0
  • Degeling C, McEwin E, Moynihan R et al. The introduction and demise of full body computed tomography (CT) scanning in Australia: implications for preventing overdiagnosis. Critical Public Health, DOI: 10.1080/09581596.2020.1841115
  • Moynihan R, Albarqouni L, Nangla C, et al. Financial ties between professional medical association leadership and industry: a cross-sectional study across ten influential United States associations. BMJ 2020;369:m1505
  • Moynihan R, Fabbri A, Parker L, et al. Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare BMJ Open 2020;10:e034195.
  • Fabbri A, O’Keeffe M, Moynihan R, et al. Media coverage of drug regulatory agencies’ safety advisories: A case study of citalopram and denosumab. Br J Clin Pharmacol. 2020;86(7):1416-1429.
  • Nickel B, Moynihan R, Barratt A, et al.  Media coverage of calls to rename low risk cancers: a content analysis. BMJ Open, BMJ Open 2020; 10:e038087.
  • Morteza A, Moynihan R, et al. “Shared decision making; how can it be helpful in reducing medical overuse due to medical misinformation mess?” Journal of Evaluation in Clinical Practice. Published 2020
  • O’Keeffe M, Barratt A, Maher CG, Zadro J, Fabbri A, Moynihan R. Media coverage of the benefits and harms of testing the healthy: a protocol for a descriptive study BMJ Open. 2019
  • McCaffery K, Nickel B, Pickles K, Moynihan R, et al.  Questioning recommended treatment for prostate cancer: a qualitative analysis of the hidden voices of men resisting overdiagnosis and overtreatment. BMJ Open. Published May 24, 2019
  • Moynihan R, Lai A, Jarvis H, Goodrick S, Duggan G, Bero L. Undisclosed financial ties to pharmaceutical companies: a cross-sectional study of clinical practice guideline writers.  BMJ Open, Published February 2019.
  • Nickel B, Semsarian S, Moynihan R, et al. Public perceptions of changing the terminology for low risk thyroid cancer: a qualitative focus group study. BMJ Open, Published 2019.
  • Nickel B, Howard K, Brito JP, Barratt A, Moynihan R, McCaffery K. Association of preferences for papillary thyroid cancer treatment with disease terminology: a discrete choice experiment. JAMA Otolaryngology – Head & Neck Surgery, 2018. [Epub ahead of print].
  • Nickel B, Barratt A, McGeechan K, Brito JP, Moynihan R, Howard K, McCaffery K. Effect of a change in papillary thyroid cancer terminology on anxiety levels and treatment preferences: a randomized crossover trial. JAMA Otolaryngology – Head & Neck Surgery, 2018. [Epub ahead of print].
  • Moynihan R, Johansson M, Maybee A, et al. Covid-19: an opportunity to reduce unnecessary healthcare. BMJ 2020;370:m2752
  • Moynihan R, Macdonald H, Bero L, et al. Commercial influence and covid-19.  BMJ 2020;369:m2456
  • Moynihan R. The voice of the people, funded now by your friendly pharmaceutical company. Journal of Bioethical Inquiry. 2020;17(1):61-63
  • Scott I, Attia J, Moynihan R. Promises and perils of using genetic tests to predict risk of disease BMJ 2020;368:m14
  • Johansson M, Bero L, Bonfill X….Moynihan R. Cochrane Sustainable Healthcare: evidence for action on too much medicine. Cochrane Database Syst Rev. 2019;12:ED000143. Published 2019 Dec 6.
  • Moynihan R, Bero L, Hill S, et al. Pathway to Independence: a plan to produce and use trustworthy evidence. BMJ, December 4, 2019.
  • Moynihan R, MacDonald H, Heneghan C, Bero L, Godlee F. Commercial Interests, transparency, and independence: a call for submissions. BMJ editorial 16 April 2019   (Ray is guest editor on forthcoming BMJ themed collection)
  • Moynihan R, Brodersen J, Heath I, et al. Reforming Disease Definitions: a new primary care led, people-centred approach. BMJ Evidence-Based Medicine. Published Online First: 08 April 2019.
  • Moynihan R, et al. Australia is responding to the complex challenge of overdiagnosis.  Medical Journal of Australia. 2018 In Press
  • Nickel B, Moynihan R, Barratt A, Brito JP, McCaffery K. Removing the cancer label from low risk conditions. BMJ . 2018
  • Moynihan R. Preventing Overdiagnosis: how can we stop harming the healthy? Chapter in Brazilian GP Textbook, Tratado de Medicinia de Familia e Comunidade 2nd Edition, 2017.
  • Nickel B, Brito JP, Moynihan R, Barratt A, Jordan S, McCaffery K. Patients experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study. BMC Cancer. 2018 Mar 2;18(1):242.
  • Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L. Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study. BMJ Open. 2018 Feb 13;8(2):e019027.
  • Semsarian C, Moynihan R. The Christmas gift of genetic uncertainty. BMJ. 2017 Dec 22;359:j5762. doi: 10.1136/bmj.j5762.
  • Pathirana T, Clark J, Moynihan R. Mapping the drivers of overdiagnosis to potential solutions. BMJ. 2017 Aug 16;358:j3879.
  • Schwartz L, Woloshin S, Heath I, Moynihan R, MacDonald H. The Overdiagnosis Community Targets Solutions BMJ Blog, August 2017 .
  • Nickel B, Barratt A, Copp T, Moynihan R, McCaffery K Words do matter: a systematic review on how different terminology for the same condition influences management preferences. BMJ Open. 2017 Jul 10;7(7):e014129.
  • Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA.A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia. BMJ Open. 2017 Jun 30;7(6):e016701
  • Nickel B, Brito JP, Barratt A, Jordan S, Moynihan R, McCaffery K.Clinicians’ Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study. Thyroid. 2017 May;27(5):661-671. doi: 10.1089/thy.2016.0483. Epub 2017 Mar 21.
  • Moynihan, R., Sims, R., Hersch, J., Thomas, R., Glasziou, P. & McCaffery, K. J.Communicating about overdiagnosis: Learning from community focus groups on osteoporosis. 1 Feb 2017 In : PLoS One. 12, 2, e0170142
  • Medew, J. & Moynihan, R. Improving coverage of medical research in a changing media environment. 18 Apr 2017 In : CMAJ. 189, 15, p. E551-E552
  • Traeger, A. C., Moynihan, R. N. & Maher, C. G.Wise choices: Making physiotherapy care more valuable. 2017 In : Journal of Physiotherapy.
  • Moynihan, R. & Bero, L. Toward a healthier patient voice: More independence, less industry funding. 17 Jan 2017 In : JAMA Internal Medicine.
  • Moynihan, R. N.Overdiagnosis and overtreatment: Beware of guidelines with expanded disease definition. 2016 Shared decision making in health care: Achieving evidence-based patient choice. Elwyn, G., Edwards, A. & Thompson, R. (eds.). Oxford University Press, p. 129-134 6 p.
  • Moynihan, R. N. Preventing overdiagnosis – winding back the harms of too much medicine 2016 In : Portuguese Journal of Nephrology and Hypertension. 30, 1, p. 14-15 2 p.
  • McCaffery, K. J., Jansen, J., Scherer, L. D., Thornton, H., Hersch, J., Carter, S. M., Barratt, A., Sheridan, S., Moynihan, R., Waller, J., Brodersen, J., Pickles, K. & Edwards, A. Walking the tightrope: Communicating overdiagnosis in modern healthcare. 5 Feb 2016 In : British Medical Journal. 352, i348
  • Moynihan, R.Caution! diagnosis creep. 1 Apr 2016 In : Australian Prescriber. 39, 2, p. 30-31 2 p.
  • Johansson, M., Jørgensen, K. J., Getz, L. & Moynihan, R. “Informed choice” in a time of too much medicine-no panacea for ethical difficulties. 9 May 2016 In : British Medical Journal. 353, i2230
  • Nickel, B., Barratt, A., Hersch, J., Moynihan, R., Irwig, L. & McCaffery, K. How different terminology for ductal carcinoma in situ (DCIS) impacts women’s concern and management preferences: A qualitative study. 2015 In : Breast. 24, 5, p. 673-679 .
  • McCaffery, K., Nickel, B., Moynihan, R., Hersch, J., Teixeira-Pinto, A., Irwig, L. & Barratt, A. How different terminology for ductal carcinoma in situ impacts women’s concern and treatment preferences: A randomised comparison within a national community survey. 2015 In : BMJ Open. 5, 11, 7 p., 008094
  • Moynihan, R. Preventing overdiagnosis: The myth, the music, and the medical meeting. 18 Mar 2015 In : British Medical Journal. 350, h1370
  • Moynihan R. Article on the proposed “female Viagra” – The Saturday Paper, July 4, 2015
  • Moynihan R. Article on expanding disease definitions – The Saturday Paper, June 20, 2015
  • Moynihan R, Nickel B, Hersch J, Doust J, Barratt A, Beller E, McCaffery K. What do you think overdiagnosis means?: a qualitative analysis of responses from a national community survey of Australians. BMJ Open, 2015;5. DOI:10.1136/bmjopen-2014-007436.
  • Moynihan R, Nickel B, Hersch J, Beller EM, Doust JA, Compton S, Barratt A, Bero L, McCaffery K. Public opinions about overdiagnosis: a national community survey. PLOS One, 2015. DOI: 10.1371/journal.pone.0125165.
  • Moynihan R, Privacy is Theft – Sharing is Caring, BMJ Column, February 5, 2014
  • Moynihan R, Act Now to Fight Chronic Procrastination Disorder (or maybe act later), BMJ Column, October 28, 2013
  • Moynihan R, Cooke G, Doust J, et. al., Expanding Disease Definitions in Guidelines and Expert Panel Ties to Industry, PLOS Medicine, August 13, 2013
  • Moynihan R, Glassock R, Doust J, The Chronic Kidney Disease Controversy , BMJ, July 30, 2013
  • Moynihan R, Doust J, Henry D, Preventing Overdiagnosis:how to stop harming the healthy, BMJ, June 2, 2012
  • Moynihan R, When less can mean more, MJA, May 21, 2012
  • Moynihan R, The dos and don’ts of collaborating with industry, BMJ, May 8, 2012
  • Moynihan R, Times like these you need some “One Four Five” – the power of music, BMJ, March 28, 2012
  • MoynihaR, One Click Transparency , MJA March 5, 2012
  • Moynihan R, A healthy dose of disinvestment MJA, February 20, 2012
  • Moynihan R, Assualting Alternative Medicine: worthwhile or witch-hunt?, BMJ, February 15, 2012
  • Moynihan R, The Greening of Medicine, BMJ, January 21, 2012
  • Moynihan R, A watchdog to bite the giants (corporate medicine), MJA column, January 16, 2012
  • Moynihan R, Forget Sponsorship and free Trips – Welcome to Pharmacare , BMJ, January 4, 2012
  • Moynihan R, How to get full meaningful disclosure, MJA column, November 21, 2011
  • Moynihan R, Is journalism the drug industry’s new dance partner?, BMJ column, November 2, 2011
  • Moynihan R, The downside of anti-depressants, MJA column, October 17, 2011
  • Moynihan R, Radio documentary with former pharmaceutical saleswoman, ABC Radio National, October 16, 2011
  • Moynihan R, Health in the Green Economy, MJA column, September 19, 2011
  • Moynihan R, Is Your Mum on Drugs?, BMJ column, August 24, 2011
  • Moynihan R, Surrogates Under Scrutiny, BMJ feature, August 15, 2011
  • Moynihan R, Pharmaville – the Latest Fad in Online Gaming, BMJ Column, July 6, 2011
  • Moynihan R, Its Time to Rebuild the Evidence Base, BMJ Column, May 25, 2011
  • Moynihan R, A New Deal on Disease Definition, BMJ feature and Cover Story, May 3, 2011
  • Moynihan R, Power to the People, BMJ Column, April 6, 2011
  • Moynihan R, Overdiagnosis and the dangers of early detection, BMJ Column, February 26, 2011
  • Moynihan R, Housing Affordability Crisis Deepens, The Echo, February 22, 2011
  • Moynihan R, Beware the fortune tellers peddling genetic tests, BMJ Column, January 8, 2011
  • Moynihan R, The merging of marketing and medical science: female sexual dysfunction, BMJ, September 30, 2010
  • Moynihan R, A Health check for the business of medicine, ABC The Drum, September 3, 2010
  • Moynihan R, Who benefits from treating Pre-hypertension?, BMJ, August 24, 2010
  • Moynihan R, Popular pills, devastating side-effects, ABC The Drum, July 12, 2010
  • Moynihan R, Drug giants secret love-in with Aussie Sexperts, ABC The Drum, June 16, 2010
  • Moynihan R, Was the swine flu a fake pandemic?, ABC The Drum, June 11, 2010
  • Robertson J, Walkom E, Moynihan R, Bero L, Henry D. Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme. International Journal of Pharmacy Practice 2010;18(2):88 – 92.
  • Moynihan R, “Health policy in times of crisis“, Health Policy Monitor, based on reports from 7 network countries, Bertelsmann Foundation, Germany, December 2009
  • Robertson J, Moynihan R, et. Al.. Mandatory disclosure of pharmaceutical industry-funded events for health professionals.PLoS Med. 2009 Nov;6(11):e1000128. Epub 2009 Nov 3.
  • D’Arcy E, Moynihan R (2009) Can the Relationship between Doctors and Drug Companies Ever Be a Healthy One? PLoS Med 6(7): e1000075.
  • Moynihan R, Doctors and drug companies: Is the dangerous liaison drawing to an end? Z. Evid. Fortbild. Qual. Gesundh. wesen (ZEFQ) 103 (2009):141–148
  • Moynihan R, Producer and Presenter of Faith and the Fix, ABC Radio National “Encounter” program on drug and alcohol addiction and naltrexone controversy. November 23, 2008
  • Schwartz L, Woloshin S, Moynihan R, ‘Who’s watching the watchdogs?’, BMJ, 2008. 2008;337:a2535
  • Moynihan R, Carlisle W, Burne M, Paying the Medical Piper, ABC Radio National, Background Briefing, February 24, 2008
  • Moynihan R, Health Firms Spruik Drug Firms, The Australian , February 22, 2008, Page 1.
  • Moynihan R, Key opinion leaders: Independent Experts or Drug Representatives in Disguise? BMJ. 2008 Jun 21;336(7658):1402-3.
  • Moynihan R, Doctors’ Education: The Invisible Influence of Drug Company Sponsorship.
    BMJ. 2008 Feb 23;336(7641):416-7.
  • Moynihan R, Burne M, Eight-part electronic- video documentary (eVD) series for WHO committee : Making Health Systems Healthier, 2008
  • Moynihan R, Oxman A, Lavis J, Paulsen E, Evidence Informed health Policy: Using Research to Make Health Systems Healthier Report to WHO committee on Evidence Informed Health Policy, 2008
  • Sweet M, Moynihan R, Improving Population Health: The Uses of Systematic Reviews
    Produced by Milbank Memorial Fund, in Collaboration with the Centers for Disease Control and Prevention (CDC), 2007
  • Moynihan R, Profile of Professor Ian Lowe, President of the Australian Conservation Foundation, Good Weekend, Sydney Morning Herald, 2005
  • Moynihan R Making medical journalism healthier The Lancet 2003;361:2097
  • Moynihan R, Three- part series on US, Australian and Swedish Health Systems
    Australian Financial Review. October 9-11, 2000
  • Moynihan R., et al Coverage by the News Media of the Benefits and Risks of Medications Abstract N Engl J Med 2000; 342:1645-1650, Jun 1, 2000
  • Tipsheet for reporting on drugs, devices and medical technologies